Turbine

24/11/2025

What happens when a scientist steps into the future of experimentation and becomes a VIRTUAL LAB SUPERUSER?

Meet Iván Fekete, Turbine Co-founder and translational biologist, using the Virtual Lab every single day to understand disease biology at a depth and speed that traditional workflows simply can’t match. Tune in on the debut episode of our Superuser series as he tackles a major question: How to combine ADC payloads to achieve synergy?

In under 5 minutes, you’ll see how the Virtual Lab empowers Iván to:
🔹simulate a myriad of virtual experiments in seconds
🔹reveal combination synergy and resistance patterns
🔹investigate the mechanisms driving cellular response on a single platform

No coding. No friction. Just intuitive in-silico experimentation that lets any scientist test all their ideas before wet lab validation. And beyond this episode, the Virtual Lab also helps researchers walk into the wet lab with sharper, more strategic plans - enhancing clinical translatability and supporting more rational decisions.

Iván uses it every day - and you could too, without needing an entire data-science team. Our virtual biology platform is a practical product already integrated into pharma R&D workflows.

Ready to become a superuser? 🚀

https://eu1.hubs.ly/H0pWNf-0

Let’s learn more about our ADC Simulation Suite here: https://eu1.hubs.ly/H0pWNd80

Meet Iván Fekete, Turbine Co-founder and translational biologist, using the Virtual Lab every single day to understand disease biology at a depth and speed t...

21/11/2025

🔥We made the Sifted Future 50 ranking!

Sifted has named us one of Europe’s rising startups showing exceptional revenue growth in their latest financial year, putting us on track to qualify for the Sifted 250 in 2026.

Scaling is tough, but with an incredible team and supportive partners, we’re building real momentum and this is just the beginning. 🚀

Some seriously impressive startups made the list, see who’s alongside us!

20/11/2025

🤖We’re heading to AI for health Summit 2025, where our Co-founder & CEO, Szabolcs Nagy, will join the panel:

“Boosting Drug Discovery with Agents & Digital Twins”
November 26, 2025 | 12:15-12:45 PM

The session will bring together leading voices shaping the future of AI-powered drug discovery, including experts from Bioptimus, EY, EPFL, and Eli Lilly to explore how virtual cells and digital twins can transform pharma R&D.

At Turbine, we’re virtualizing biological experiments with AI to accelerate discovery and improve clinical translatability.

If you’re attending and want to explore collaboration opportunities or learn more about our approach, feel free to reach out to our team: Pier Giorgio, Luca Bárdió, and Szabolcs Nagy.

See you in Paris!🥐

19/11/2025

So… what is a virtual cell?
In its ideal form, a virtual cell would be a complete, general simulation of biology - one that can accurately predict outcomes in entirely new contexts without retraining.

💡This is the dream. And it’s not something we have today and that’s perfectly okay.
Yet over the past year, virtual cells have become one of the most hyped topics in biotech and AI. And as with any hype cycle, the noise often makes it hard to see what the technology can really do today and what it can’t.

What we have today are narrow virtual cell models that can predict outcomes within a well-defined assay, where we have sufficient calibration data. These are already virtualizing many experiments with impressive accuracy (through what we call virtual assays).

At Turbine we already have a ready-to-use, practical product built on this principle, one that pharma teams are already integrating directly into their workflows.

👉Read our Founder & CTO Kristof Szalay's blog post for the deeper explanation here:

and what they can't - because the bottleneck is not computing power

18/11/2025

This week, we’re heading to the scverse Conference at Stanford University - right into the heart of the virtual cell conversation, with teams like Tahoe Therapeutics Arc Institute and Chan Zuckerberg Initiative in the room. As one of the few teams in the virtual biology space, with a practical and consumable product already integrated into pharma workflows, we’re bringing hands-on experience to the table. Our ready-to-use Virtual Lab is actively supporting drug discovery teams today and we’re excited to share what we’ve learned.

We’re also presenting a poster, and we’d love for you to stop by. Our poster examines why masking-based pretraining doesn’t enhance perturbation modeling - and the useful insight behind this outcome. Come see our poster at 4.15pm PDT and join the conversation with Bence Szalai Bence Czakó, PhD Richard Izrael, PhD.

https://eu1.hubs.ly/H0pJr_p0

05/11/2025

Turbine is everywhere 👀

We’ve just landed in Vienna for BIO-Europe and in San Diego for World ADC - ready to get inspired, share ideas, and give back to the scientific community.

For over a decade, we’ve been building and refining a true virtual biology platform that pharma and biotech teams can integrate directly into their R&D workflows. This journey has made us the first company to bring virtual experiments from concept to real scientific practice & now, you can see it in action!

Come check out our Virtual Lab demo at Booth C198 (Vienna) or Booth 118 (San Diego).

Can’t make it this time? No worries, you can find all the details on our website: https://eu1.hubs.ly/H0pnmF30

28/10/2025

We’re proud to announce that Turbine has been nominated for the 2025 Prix Galien USA Award in the Best Startup category! 🏅

The Prix Galien Awards, often called the “Nobel Prize for biopharma innovation,” recognize outstanding achievements that improve the human condition through biomedical innovation.

This nomination celebrates our mission to virtualize biological experiments with AI to accelerate drug discovery and enhance clinical translatability. It also recognizes the impact our team is making toward transforming how the world develops new therapies, ultimately helping to create novel treatments that cure patients.

We’re honored to stand among such inspiring innovators, and we’ll be cheering on Louisa Roberts, our CBO, who will represent Turbine at the award ceremony on October 30th in New York City.

Read more about the nominees:
https://eu1.hubs.ly/H0p9WDh0

22/10/2025

🚀We are thrilled to welcome Louisa Roberts as our new Chief Business Officer!

Louisa has spent her career in LifeSciences and held leadership positions in large corporations (ICON, IBM) as well as small privately funded companies. She brings expertise in corporate and commercial strategy, sales leadership and strategic deal ex*****on that advances innovation in drug discovery and development. Her collaborative approach enables her to develop high impact partnerships across the biopharma ecosystem.

Louisa joins Turbine at a pivotal moment in our growth as we help biopharma accelerate drug discovery and enhance clinical translatability through the adoption of simulated biological experiments. Our ambition is to integrate our Virtual Lab platform across pharma R&D workflows, her leadership will help drive new customers, data partners and channels.

Please join us in giving Louisa a warm welcome to the Turbine team!👏

17/10/2025

🏙️ Turbine will be exhibiting at BIO-Europe Fall, November 3–5, 2025 in Vienna!

🙋‍♂️ Meet members of our Business Development team, Balázs Horváth (Associate) and Pier Giorgio Pacifici (Director), at booth C 198 in the Vienna Congress and Convention Center. Attendees are invited to experience our Virtual Lab on-site, to see how simulated experiments accelerate workflows and decision-making in R&D!

Interested? Connect with our team in the exhibit hall, even during the evening reception!

See you in Vienna!​

16/10/2025

🏙️ Turbine is heading to World ADC San Diego from November 3–6, 2025!

💊💊 Our team will be presenting new research on dual ADC payload synergy, leveraging Turbine’s Simulated Cell Platform and automated wet lab.

Meet our team on-site:

Louisa Roberts – Chief Business Officer
Neeraj Rao – Business Development Director
Ákos Tarcsay – Product Manager
Jerzy Woźnicki – Scientific Project Lead
Bálint Paholcsek – Head of MarCom

Don’t miss Jerzy's 15-minute talk about our poster and technology (November 5, 12:45pm). If you’d like to connect, reach out directly to any of our team members.

See you in San Diego!​

14/10/2025

🏙️ Our team is heading to ESMO Congress 2025 in Berlin (October 17-21)

Looking to explore collaborations or learn more about our 🖥️🔬 Virtual Lab platform? Reach out to any of our team members directly.

Szabolcs Nagy - CEO & Co-founder
Daniel Veres, MD, PhD - CSO & Co-founder
Krishna C. Bulusu - VP of Product Innovation & Strategy
Tamás Török - Head of Business Development
István Taisz, MD - Scientific Project Manager
Luca Bárdió - PR & Storytelling

See you in Berlin.​

13/10/2025

Fierce Biotech summed up our joint mission with AstraZeneca well: rationalizing ADC discovery by creating a simulate-test-learn cycle that helps scientists focus on the experiments that matter most.

For us, this is all about making simulations an essential part of the pharma R&D workflow, giving every scientist the ability to test virtually all hypotheses and explore only what truly matters in the wet lab.

This collaboration with AstraZeneca is a leap toward that vision. 🚀

Read more here:

AstraZeneca is once again teaming up with Hungarian artificial intelligence specialist Turbine as it looks to speed up and gain deeper insights into its antibody-drug conjugate discovery process.